This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: R&d-Biopharmaceuticals Gmbh. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Katrin Illgen: Innovator in Biopharmaceuticals
Introduction
Katrin Illgen is a notable inventor based in Planegg, Germany. She has made significant contributions to the field of biopharmaceuticals, particularly through her innovative work on tubulysin analogues. Her research focuses on developing compounds with potential therapeutic applications.
Latest Patents
Katrin Illgen holds 1 patent for her invention titled "Tubulysin analogues." This invention relates to tubulysin derivatives of general formula (II), which exhibit a cytostatic effect. Her work in this area has the potential to impact cancer treatment and other medical applications.
Career Highlights
Throughout her career, Katrin has worked with various organizations, including R&D-Biopharmaceuticals GmbH. Her expertise in biopharmaceuticals has allowed her to contribute to advancements in drug development and therapeutic solutions.
Collaborations
Katrin has collaborated with notable professionals in her field, including Alexander Dömling and Bernd Henkel. These partnerships have enhanced her research and broadened the impact of her innovations.
Conclusion
Katrin Illgen's contributions to the field of biopharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical science.